BioNTech SE
$95.50
$3.85(-3.88%)
BioNTech SE
BNTX
$95.50
$3.85(-3.88%)
BioNTech SE
BNTX
NASDAQ
$95.50
$3.85(-3.88%)
Chart
Upcoming Earnings
Next report date
Aug 3, 2026
Report period
Q3 2026
EPS Estimate
$-2.42
Revenue Estimate
$282.50M
Key stats
52-Week Range$95.50
$79.52
$124.00
Market capitalization
$24.00BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-19.18Basic EPS (TTM)
$-4.68Net income (TTM)
$-1.13BRevenue (TTM)
$2.86BAvg. volume
1.11MBeta (1Y)
1.37Employees
6.77KMarket capitalization
$24.00BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-19.18Basic EPS (TTM)
$-4.68Net income (TTM)
$-1.13BRevenue (TTM)
$2.86BAvg. volume
1.11MBeta (1Y)
1.37Employees
6.77KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout BioNTech SE
Sector
Healthcare
Industry
Biotechnology
CEO
Ugur Sahin
Website
www.biontech.deHeadquarters
An der Goldgrube 12, Mainz, 55131
IPO Date
2019-10-10
Identifiers
ISIN
US09075V1026Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The...
Related Stocks
$35.86
1D:
1.4%
1Y:
118.8%
US8816242098Healthcare
Mkt Cap
$41.76B
P/E Ratio TTM
25.7
Revenue TTM
$17.26B
Beta
0.86
Earnings TTM
$1.41B
Dividend Yield TTM
0.00%
$206.77
1D:
-2.3%
1Y:
31.4%
US6323071042Healthcare
Mkt Cap
$29.31B
P/E Ratio TTM
-136.1
Revenue TTM
$2.31B
Beta
1.68
Earnings TTM
$-208.16M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate